Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8731)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2019 (publication date) through Feb 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Barone M, Viggiani MT, Losurdo G, Principi M, Leo AD. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma. World J Gastroenterol 2019; 25(20): 2524-2538 [PMID: PMC6543242 DOI: 10.3748/wjg.v25.i20.2524] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i20/2524.htm |
| Number | Citing Articles |
| 1 |
Alexander Kusnik, Nicole Hunter, Erik Rasbach, Thomas Miethke, Christoph Reissfelder, Matthias Philip Ebert, Andreas Teufel. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular Carcinoma. Digestive Diseases 2021; 39(5): 526 doi: 10.1159/000514277
|
| 2 |
Atamjit Singh, Preet Mohinder Singh Bedi. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25: 379 doi: 10.1007/978-3-031-23621-1_18
|
| 3 |
Yee Hui Yeo, Manal Abdelmalek, Seema Khan, Cynthia A. Moylan, Luz Rodriquez, Augusto Villanueva, Ju Dong Yang. Current and emerging strategies for the prevention of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2024; doi: 10.1038/s41575-024-01021-z
|
| 4 |
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang, Jian-Hong Zhong. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1077 doi: 10.1080/17474124.2019.1684898
|
| 5 |
Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Huapeng Lin, Guan‐Lin Li, Jimmy Che‐To Lai, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong. Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease. Hepatology 2022; 76(2): 469 doi: 10.1002/hep.32294
|
| 6 |
Michele Barone. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?. World Journal of Gastroenterology 2024; 30(18): 2391-2396 doi: 10.3748/wjg.v30.i18.2391
|
| 7 |
Rong Yang, Yonggang Zhang, Xiaoyang Liao, Yi Yao, Chuanying Huang, Lixia Liu. The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.610157
|
| 8 |
José A. Carlos-Escalante, Marcela de Jesús-Sánchez, Alejandro Rivas-Castro, Pavel S. Pichardo-Rojas, Claudia Arce, Talia Wegman-Ostrosky. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.660943
|
| 9 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22): 6770 doi: 10.3390/jcm13226770
|
| 10 |
Fereshteh Asgharzadeh, Reza Jafarzadeh-Esfehani, Seyed M. Hassanian, Gordon A. Ferns, Amir Avan, Majid Khazaei. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Current Pharmaceutical Design 2020; 26(39): 5079 doi: 10.2174/1381612826666200713165018
|
| 11 |
Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida. Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic. Hepatology 2025; doi: 10.1097/HEP.0000000000001227
|
| 12 |
Ruixing Zhang, Hongtao Yin, Mengdi Yang, Jinjin Liu, Donghu Zhen, Zheng Zhang. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers. Journal of Hypertension 2024; 42(11): 1862 doi: 10.1097/HJH.0000000000003836
|
| 13 |
Manoj Kumar Kashyap, Anjali Bhat, Divya Janjua, Rashmi Rao, Kulbhushan Thakur, Arun Chhokar, Nikita Aggarwal, Joni Yadav, Tanya Tripathi, Apoorva Chaudhary, Anna Senrung, Alok Chandra Bharti. Angiotensin. 2023; : 505 doi: 10.1016/B978-0-323-99618-1.00019-2
|
| 14 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
|
| 15 |
Harry Crane, Cameron Gofton, Ankur Sharma, Jacob George. MAFLD: an optimal framework for understanding liver cancer phenotypes. Journal of Gastroenterology 2023; 58(10): 947 doi: 10.1007/s00535-023-02021-7
|
| 16 |
Adriana Albini, Douglas M. Noonan, Paola Corradino, Francesca Magnoni, Giovanni Corso. The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention. Cancer Prevention Research 2024; 17(7): 289 doi: 10.1158/1940-6207.CAPR-24-0085
|
| 17 |
Kwang Min Kim, Ji Hye Roh, Sangjin Lee, Jeong-Hyun Yoon. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101510 doi: 10.1016/j.clinre.2020.07.015
|
| 18 |
Hai-Feng Zhang, Xiang Gao, Xuan Wang, Xin Chen, Yu Huang, Lang Wang, Zhou-Wei Xu. The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomedicine & Pharmacotherapy 2021; 141: 111868 doi: 10.1016/j.biopha.2021.111868
|
| 19 |
Zhou-wei Xu, Na-na Liu, Xing-yu Wang, Bai-cheng Ding, Hai-feng Zhang, Ying Li, Wu-yi Sun, Wei Wei. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02261-8
|
| 20 |
Mary S. McGrath, Brian J. Wentworth. The Renin–Angiotensin System in Liver Disease. International Journal of Molecular Sciences 2024; 25(11): 5807 doi: 10.3390/ijms25115807
|
| 21 |
Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi, Tlili Barhoumi. The Effect of Local Renin Angiotensin System in the Common Types of Cancer. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.736361
|
| 22 |
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?. Cancers 2023; 15(11): 2950 doi: 10.3390/cancers15112950
|
| 23 |
In-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, Chae Young Kang, Jinseub Hwang, Chang Hee Kwon, Woohyeun Kim, Dae-Hee Kim, Chan Joo Lee, Si-Hyuck Kang, Ju-Hee Lee, Hack-Lyoung Kim, Hyue Mee Kim, Iksung Cho, Hae-Young Lee, Wook-Jin Chung, Sang-Hyun Ihm, Kwang Il Kim, Eun Joo Cho, Il-Suk Sohn, Sungha Park, Jinho Shin, Sung Kee Ryu, Jang Young Kim, Seok-Min Kang, Myeong-Chan Cho, Wook Bum Pyun, Ki-Chul Sung. Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study. Journal of Clinical Medicine 2021; 10(4): 771 doi: 10.3390/jcm10040771
|
| 24 |
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, Simonetta Bandiera, Naoto Fujiwara, Hussein El Saghire, Shijia Zhu, Tongqi Qian, Fahmida Akter Rasha, Fabio Del Zompo, Stephen C. Barrett, Eugénie Schaeffer, Marine A. Oudot, Clara Ponsolles, Sarah C. Durand, Sarani Ghoshal, Gunisha Arora, Fabio Giannone, Raymond T. Chung, Nevena Slovic, Nicolaas Van Renne, Emanuele Felli, Patrick Pessaux, Joachim Lupberger, Nathalie Pochet, Catherine Schuster, Kenneth K. Tanabe, Yujin Hoshida, Bryan C. Fuchs, Thomas F. Baumert. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight 2022; 7(13) doi: 10.1172/jci.insight.159254
|